Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

News In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

Syneron buys UltraShape. Smith & Nephew settles foreign bribery charges. Hospitals settle kyphoplasty allegations. More news briefs.

You may also be interested in...



News In Brief

Merit snaps up Thomas Medical. Halma buys MicroSurgical Technology. Sanofi settles Hyalgan charges. More news briefs.

News In Brief

GE Healthcare buys U-Systems for breast ultrasound device. Bausch & Lomb snaps up Technolas Perfect Vision. Orthofix settles Blackstone kickbacks case. More news briefs.

News In Brief

Orthofix settles foreign bribery charges. Cardiosolutions wins $8 million investment for mitral valve technology. OraSure plans $75 million stock offering. More news in brief.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight
Medtech Insight
Medtech Insight

Topics

Related Companies

Tags:
Medical Device
Latest Headlines

Global Medtech Guidance Tracker: September 2023

‘Build A Company To Be Bought, Not Sold,' 'Match The Asset To The Capital,' And Other Advice From Medtech Venture Capital Experts

Warning Letters And Close-Outs – September 2023

Minute Insight: Cordis-MedAlliance Deal Formalized, Less Than One Year After Announcement

See All
UsernamePublicRestriction

Register

MT030962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By